- Gold bounces off $1,825 to pare the biggest losses since November 23.
- Risks dwindle as traders turn cautious ahead of the key risk decisions.
- UK PM Johnson’s visit to Brussels, US FDA’s vaccine approval and stimulus passage keep traders worried.
- Gold ETFs marked the first outflows of the year in November.
Gold prices nurse recent losses while picking up bids near $1,840 during the early Thursday morning in Asia. The yellow metal not only snapped the two-day winning streak while reversing from the two weeks high but also posted the heaviest declines in 13 days the previous day. The shift in the risks and news concerning the outflow of the gold Exchange Traded Funds (ETFs) did the most harm to the bullion. Additionally, the market’s cautious mood ahead of the important announcement relating to Brexit, US stimulus and the coronavirus (COVID-19) vaccine also weighed the quote.
Bears cheer aftershocks of bad November…
Having witnessed the biggest monthly losses in four years during November, gold traders also took out from the ETF holdings, by 107 tonnes, during the stated period. This marks the first negative print of the ETF statement in the year and offered an additional reason for the bullion sellers, other than the earlier advances of equities, to move away from the commodities.
Even if the equities bear the burden of uncertainty over US stimulus and Brexit during the US session on Wednesday, gold sellers kept the reins as the US dollar rose for the fourth consecutive day amid a cautious mood. The risk aversion, or consolidation, could also be traced to the increasing COVID-19 cases from the US and wait for the vaccine. Furthermore, the US-China tussle and move in the up-move US real yields also dragged the precious metal the previous day.
Amid these plays, Wall Street benchmarks couldn’t please the bulls, with Nasdaq witnessing the worst day in a month after refreshing the record top, whereas the US 10-year Treasury yields rose around 2.5 basis points (bps) by the end of Wednesday’s North American session.
Looking forward, market players are eagerly waiting for the comments from Brussels as well as any updates on the US stimulus, even if the stopgap funding is passed, for fresh impulse. Also in the pipeline is the ECB decision and the US Food and Drug Administration’s (FDA) approval of Pfizer’s vaccine. While most of the stated decisions are likely to come in positive, any surprises won’t be taken lightly and may offer further room to gold sellers.
Technical analysis
Failures to cross 50-day SMA, currently around $1,876, pull gold prices backward to highs marked in early July and late November near $1,818/17.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD drops below 1.0800 after German Retail Sales data
EUR/USD has come under fresh selling pressure and trades below 1.0800 after the data from Germany showed that Retail Sales declined by 1.9% MoM in February. Resurgent US Dollar demand is adding to the downside in the pair. US data are next in focus.
GBP/USD stays weak near 1.2600 amid market caution
GBP/USD remains defensive near 1.2600 in European trading on Thursday. The hawkish tone from Fed Governor Christopher Waller keeps the US Dollar afloat amid a cautious trading environment ahead of key US data releases and the Good Friday trading lull.
Gold price bulls keenly await US PCE Price Index on Friday before placing fresh bets
Gold price (XAU/USD) continues with its struggle to make it through the $2,200 mark on Thursday and oscillates in a narrow trading band through the early part of the European session.
XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC
XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase.
The other terminal rate: How far will policy rates be cut?
Recent communication by the Federal Reserve and the ECB has made it clear that the first cut in official interest rates is coming. Both central banks are saying the same but the ECB communication is more opaque than that of the Fed.